Bladder Cancer Cell Transitional
2 clinical trials · Condition
◉ Watch Bladder Cancer Cell Transitional
| Record | Firm | Date |
|---|---|---|
| Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer (NCT03081858) | Lipac Oncology LLC | 2018-05-17 |
Track Bladder Cancer Cell Transitional automatically
Every clearance here is in the API, with alerts when new ones post.